Literature DB >> 9184776

Assay reproducibility of hormone measurements in postmenopausal women.

R T Falk1, J F Dorgan, L Kahle, N Potischman, C Longcope.   

Abstract

As part of a breast cancer case-control study of serum hormones conducted in Columbia, MO, we included several replicate quality control samples to monitor the consistency of laboratory assays. Sera were obtained from three postmenopausal women; from each woman, three samples were placed randomly in each of nine batches with the laboratory unaware of which sample corresponded to whom. Laboratory assays for estrone (E1), estradiol (E2), testosterone, androstenedione (Adione), E1SO4, dehydroepiandrosterone sulfate (DHEAS), follicle-stimulating hormone (FSH), sex hormone binding globulin (SHBG), and percentages of free and albumin-bound E2 were done at a single academic facility. ANOVA results showed that hormone values varied considerably from one batch to the next. The overall coefficients of variation (CVs) estimated for E2, percentage of unbound E2, and percentage of albumin-bound E2 were higher than 15%, but of these, only percentage of unbound E2 had both inter- and intra-assay CVs greater than 10%. Intraclass correlations (ICC) for FSH, SHBG, and DHEAS were high, suggesting that these assays are suitable for population-based studies attempting to link hormone levels to disease risk. The ICC estimated for E1SO4 was quite low due to aberrant values reported in a single batch. For the remaining hormones, the ICCs were fair (ranging from 47% for albumin-bound E2 to 67% for Adione), and studies using these assays would require a substantial increase in the sample size to detect small case-control differences.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184776

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

1.  An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors.

Authors:  Jing Fan; Roberta McKean-Cowdin; Leslie Bernstein; Frank Z Stanczyk; Arthur Xuejun Li; Rachel Ballard-Barbash; Anne McTiernan; Richard Baumgartner; Frank Gilliland
Journal:  Breast Cancer Res Treat       Date:  2006-06-05       Impact factor: 4.872

2.  Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.

Authors:  Page E Abrahamson; Shelley S Tworoger; Erin J Aiello; Leslie Bernstein; Cornelia M Ulrich; Frank D Gilliland; Frank Z Stanczyk; Richard Baumgartner; Kathy Baumgartner; Bess Sorensen; Rachel Ballard-Barbash; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2006-11-01       Impact factor: 4.872

3.  Reproducibility of serum pituitary hormones in women.

Authors:  Alan A Arslan; Yian Gu; Anne Zeleniuch-Jacquotte; Karen L Koenig; Mengling Liu; Lyudmila Velikokhatnaya; Roy E Shore; Paolo Toniolo; Faina Linkov; Anna E Lokshin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

4.  Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.

Authors:  E R Sauter; H Ehya; J Babb; E Diamandis; M Daly; A Klein-Szanto; E Sigurdson; J Hoffman; J Malick; P F Engstrom
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

5.  The challenge of measuring circulating estradiol at low concentrations.

Authors:  Paolo Toniolo; Annekatrin Lukanova
Journal:  Breast Cancer Res       Date:  2005-01-12       Impact factor: 6.466

6.  Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Naomi E Allen; Timothy J Key; Laure Dossus; Sabina Rinaldi; Anne Cust; Annekatrin Lukanova; Petra H Peeters; N Charlotte Onland-Moret; Petra H Lahmann; Franco Berrino; Salvatore Panico; Nerea Larrañaga; Guillem Pera; Maria-José Tormo; Maria-José Sánchez; J Ramón Quirós; Eva Ardanaz; Anne Tjønneland; Anja Olsen; Jenny Chang-Claude; Jakob Linseisen; Mandy Schulz; Heiner Boeing; Eva Lundin; Domenico Palli; Kim Overvad; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Sheila Bingham; Kay-Tee Khaw; H Bas Bueno-de-Mesquita; Antonia Trichopoulou; Dimitiros Trichopoulos; Androniki Naska; Rosario Tumino; Elio Riboli; Rudolf Kaaks
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

7.  Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study.

Authors:  Roni T Falk; Louise A Brinton; Joanne F Dorgan; Barbara J Fuhrman; Timothy D Veenstra; Xia Xu; Gretchen L Gierach
Journal:  Breast Cancer Res       Date:  2013-04-22       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.